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The dearth of new antibiotics in the face of widespread antimicrobial resistance
makes developing innovative strategies for discovering new antibiotics critical for the
future management of infectious disease. Understanding the genetics and evolution
of antibiotic producers will help guide the discovery and bioengineering of novel
antibiotics. We discovered an isolate in Alaskan boreal forest soil that had broad
antimicrobial activity. We elucidated the corresponding antimicrobial natural products
and sequenced the genome of this isolate, designated Streptomyces sp. 2AW.
This strain illustrates the chemical virtuosity typical of the Streptomyces genus,
producing cycloheximide as well as two other biosynthetically unrelated antibiotics,
neutramycin, and hygromycin A. Combining bioinformatic and chemical analyses, we
identified the gene clusters responsible for antibiotic production. Interestingly, 2AW
appears dissimilar from other cycloheximide producers in that the gene encoding
the polyketide synthase resides on a separate part of the chromosome from
the genes responsible for tailoring cycloheximide-specific modifications. This gene
arrangement and our phylogenetic analyses of the gene products suggest that
2AW holds an evolutionarily ancestral lineage of the cycloheximide pathway. Our
analyses support the hypothesis that the 2AW glutaramide gene cluster is basal
to the lineage wherein cycloheximide production diverged from other glutarimide
antibiotics. This study illustrates the power of combining modern biochemical
and genomic analyses to gain insight into the evolution of antibiotic-producing
microorganisms.
Keywords: glutaramide antibiotics, cycloheximide, neutramycin, hygromycin A, natural product biosynthesis,
bioinformatics
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INTRODUCTION
The Actinobacteria comprise a large bacterial phylum
commonly found in soil and aquatic environments. Within
the Actinobacteria, the genus Streptomyces has been a source of
diverse and clinically important bioactive metabolites, including
the antibiotics streptomycin and tetracycline, the antifungal
amphotericin B, the antihelminthic avermectin, the antitumor
mitomycin C, and the immunosuppressants rapamycin and
tacrolimus (FK506). Streptomyces genomes are typically large
(8–10 Mb), extremely G+C-rich, and often encode multiple
biosynthetic gene clusters for secondary metabolites. For
example, up to twenty-five such clusters were identified in
the genome of Streptomyces avermitilis (Ikeda et al., 2003).
These metabolites often work synergistically, as in the case
of cephamycin C, a beta-lactam antibiotic, and clavulanic
acid, a beta-lactamase inhibitor produced by Streptomyces
clavuligerus (Jensen and Paradkar, 1999). These secondary
metabolites are not essential for bacterial growth but instead
have important ecological roles in mediating microbe–microbe
and bacteria–host interactions. There are several mutualistic
interactions reported where diverse invertebrates and plants
guard and feed different Streptomyces strains, with the symbionts
apparently producing various secondary metabolites to protect
their host from pathogenic microorganisms (Seipke et al., 2012).
Humankind has exploited these secondary metabolites, with the
use of antibiotics being one of the greatest medical advances of
the 20th century.
Given the increasing number of multidrug-resistant bacteria
and the threat that antibiotics in current use will lose efficacy
toward many pathogens, further characterization of Streptomyces
spp. and other Actinobacteria is important to help fill the critical
need for new antibiotics. Despite being tapped as antibiotic
sources for decades, it is estimated that Streptomyces spp.
potentially produce up to 100,000 antimicrobial metabolites,
of which only a small proportion have been identified (Watve
et al., 2001). Understanding how the Actinobacteria evolved
such a diverse chemical arsenal will further enable strategies to
engineer new, or as yet undiscovered, metabolic pathways and
may translate to the design and production of new antibiotics
in vitro.
The chemical complexity of known Actinobacterial
secondary metabolites is reflected in similarly complex genetic
underpinnings. For example, Saccharopolyspora erythraea
expresses 20 genes to produce the macrolide antibiotic
erythromycin (Staunton and Wilkinson, 1997). The genes
for particular secondary metabolite biosynthetic pathways tend
to be clustered, a feature thought to permit their co-regulation
and spread by horizontal gene transfer. On the other hand,
new chemistries can arise through distinct genetic pathways,
which may be unlinked originally, but later join together in
the same genome. Accordingly, the discovery of new chemical
scaffolds or modifications to known molecules will often
dovetail with the elucidation of their genetic evolution. Such
analyses will be aided by the increasing number of complete
or draft bacterial genomes available, including many for
Streptomyces species. This genomic database creates a unique
opportunity to identify diverse biosynthetic gene clusters and
understand how these secondary metabolite pathways evolve,
diversify, and generate the high chemical diversity present in
Streptomyces.
Here, we report the characterization of Streptomyces sp.
2AW, an Alaskan soil isolate that produces at least three
structurally unrelated antimicrobial metabolites – hygromycin
A, neutramycin, and cycloheximide. By using large amounts
of high-quality genomic DNA, which reduced the need for
extensive PCR amplification, we were able to overcome the
challenges inherent in sequencing a large, G+C-rich genome.
We used sequence alignment and protein prediction algorithms
to identify the putative biosynthetic gene clusters for the three
antimicrobial metabolites. Unexpectedly, we found that the
genes of the cycloheximide biosynthetic pathway of Streptomyces
sp. 2AW are separated into two independent clusters in the
genome. Based on phylogenetic analysis and data mining of
several cycloheximide-like gene clusters in the genomes of other
Streptomyces species, we propose an evolutionary framework for
cycloheximide and other glutarimide metabolites in which the
gene clusters diversified from a conserved polyketide synthase
with five modules.
MATERIALS AND METHODS
Culture Conditions
Streptomyces sp. strain 2AW was collected from boreal forest soil
in Alaska as described elsewhere (Schloss et al., 2010) and then
cultured on oatmeal agar plates (60 g oatmeal and 12.5 g agar per
liter water, mixed in a blender until mostly smooth, pH adjusted
to 6.0 with NaOH or HCl, autoclaved 45 min at 120◦C, shaken,
then poured into 100-mm Petri dishes). Cultures were grown at
28◦C for 2 weeks or until covered with gray spores. Spores were
collected by flooding plates with water and rubbing off the spores
using sterile plastic loops. Spore suspensions were then vortexed,
briefly sonicated, and stored at −80◦C. Pythium ultimum was
a gift from the laboratory of Scott Strobel (Yale University). It
was cultured on the benchtop on potato dextrose media (Difco
Laboratories, Detroit).
Bioassays for Antimicrobial Activity
For measuring antibacterial activity, approximately 1–5 mg of
each fraction (dry weight) was spotted on Luria-Bertani agar
(LBA). A 120 µL overnight culture of Escherichia coli or Bacillus
subtilis was mixed with 12 mL of soft LBA (0.8% agar) and poured
over each plate. Plates were incubated overnight at 28◦C and
then inspected for zones of inhibition. Eukaryotic inhibition was
assayed by spotting one side of a potato dextrose or International
Streptomyces Project Media #2 (ISP2) plates with each fraction, as
above, and adding a plug of Pythium-containing potato dextrose
agar to the other (Shirling and Gottlieb, 1966). Plugs were taken
from plates after 3–6 days of Pythium growth using autoclaved
sections of plastic drinking straws. Inhibition was determined
by zones of reduced growth of Pythium after 2 days at room
temperature.
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Chromatography
Compounds were purified using a Biotage Isolera One system
with a 12-g SiliCycle C18 17% cartridge, 230- to 400-µm
particle size, and a 40- to 63-µm mesh or the Shimadzu
LC-20AT high pressure liquid chromatograph with a Restek
Ultra II C18 reversed-phase column (150 mm length, 4.6-
mm i.d., 5.0-µm particle size, and 100-Å pore size). Liquid-
chromatography/mass spectrometry was performed on a Waters
Synapt G1 Q-TOF mass spectrometer coupled to a Waters
Acquity UPLC. Data were routinely collected under positive
electrospray conditions.
Small Molecule Purification
For extraction of Streptomyces metabolites from solid cultures,
cultures were grown on ISP2. Agar was removed from culture
plates, placed in glass vessels, frozen at−80◦C for 1–3 h, defrosted
at room temperature for 1 h, and submerged in methanol. The
glass vessels were shaken at room temperature for 8 h, and agar
was filtered from the crude extract with a sintered-glass funnel
and under vacuum.
For purification of metabolites from solid culture, crude
Streptomyces sp. 2AW extract was obtained from 90 ISP2 plates
(30 mL each) as described above. The extract was concentrated
using a rotary evaporator. Approximately 0.75 g of crude extract
was resuspended in 1 mL of deionized water and purified using
the Biotage Isolera system using an RP-C18 cartridge. The full
gradient ran from 5% acetonitrile increasing to 15% over 25 min,
then to 40% over 11 min, then to 100% over 2 min and held at
100% for 4 min at a flow rate of 12 mL/min. Fractions that eluted
with 30% acetonitrile were found to contain cycloheximide,
which was determined to be the active component against P.
ultimum in extracts of Streptomyces sp. 2AW. Fractions on
either side of the cycloheximide-containing fraction exhibited a
range of antibacterial activity, but they had no activity against
P. ultimum. The amounts of these components isolated from
this initial column were too low, and the they were not pure
enough, for structure determination. Scale-up of the culturing
and purification process for Streptomyces sp. 2AW extracts
involved fractionation using multiple runs of reversed-phase
C18 chromatography by either HPLC or the Biotage Isolera
system. Fractions were pooled following identification based
on activity against either both Gram-positive (B. cereus) and
Gram-negative (E. coli) or Gram-positive only, as determined
using overlay assays. The Biotage gradient was as follows: 5%
acetonitrile increasing to 15% over 25 min, then to 40% over
11 min, then to 100% over 2 min and held at 100% for 4 min
at a flow-rate of 12 mL/min. The material active against both
Gram-positive and Gram-negative bacteria eluted between 9 and
21 min; the material active only against Gram-positive bacteria
eluted between 25 and 41 min. The HPLC gradient was as
above; the material active against both Gram-positive and Gram-
negative bacteria eluted between 19 and 21 min, and the material
active against Gram-positive bacteria only eluted only between 34
and 38 min.
These compounds were obtained from a total of 3.2 L
of Streptomyces sp. 2AW culture grown on ISP2 agar and
extracted as described above. The combined active fractions
were purified further by reversed-phase HPLC. Yields for the
purified materials were: 7 mg of the compound active against
both Gram-positive and Gram-negative bacteria (hygromycin A
and/or epi-hygromycin A, and methoxyhygromycin A), and 3 mg
of neutramycin, the compound active against only Gram-positive
bacteria.
Elucidation of Antibiotic Structures
Nuclear magnetic resonance (NMR) spectra were recorded in
D2O, CD3OD, or CDCl3 at 25◦C using Bruker Avance 500 MHz,
Varian Inova 500 MHz, and Agilent 600 MHz (3 mm cold probe)
instruments, as indicated on the spectra in the Supplementary
Figures S1–S4 and Supplementary Tables S1–S3. Spectra run
in D2O were not re-referenced. Spectra run in CD3OD were
referenced to the residual solvent peaks at 3.31 ppm and
49.0 ppm for 1H and 13C NMR, respectively. Spectra run in
CDCl3 were referenced to residual solvent peaks at 7.25 and
77.0 ppm for for 1H and 13C NMR, respectively. Accurate-
mass MS data were recorded on a Waters Synapt G1 mass
spectrometer after calibration with a sodium formate solution
with a mass range from 100 to 2000 m/z. System suitability was
obtained during each run, in which the difference between the
calculated and observed m/z values were less than 5 ppm for
each of four standard compounds, with m/z ranging from 152
to 609.
DNA Sequence Analysis
Initial sequencing of Streptomyces sp. 2AW was conducted by
the J. Craig Venter Institute using a GS FLX platform. Further
library construction and sequencing were performed by the
Yale Center for Genome Analysis1. One µg of high quality
genomic DNA was sonically sheared to an average fragment
size of 1 kb (Covaris). gDNA was obtained using a standard
genomic phenol–chloroform extraction (Kieser et al., 2000),
purified using magnetic AMPure XP beads (Beckman Coulter),
selectively precipitated by mass and re-bound to the beads using
a 20% polyethylene glycol, 2.5-M NaCl solution. The fragments
were given blunt, phosphorylated ends with T4 DNA polymerase
and T4 polynucleotide kinase. A single adenine residue was added
to the 3′ end of each fragment, and custom adapters (IDT) were
ligated to each fragment using T4 DNA ligase. The library was
run on a 2% pre-cast gel (Invitrogen) and ∼1-kb inserts were
excised, subjected to three cycles of PCR amplification using
custom-made primers (IDT) containing unique 6-bp indices. The
library was sequenced on an Illumina MiSeq using 2 bp× 250 bp
reads.
454 paired-end reads were assembled using Newbler
software2 with default settings, generating 16 scaffolds.
Illumina reads were first trimmed using Trimmomatic
(Bolger et al., 2014), using the follow setting LEADING:30
TRAILING:30 SLIDINGWINDOW:7:30 MINLEN:2. Gaps in
the scaffolds were closed using the trimmed Illumina reads
by GapFiller (Boetzer and Pirovano, 2012) with the follow
1http://medicine.yale.edu/keck/ycga/index.aspx
2http://www.454.com/products/analysis-software/
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settings: bwa algorithm; 722, average insert length; 0.30,
insert length expected error; 20, m; 2, o; 5, t; 0.7, r; 15, n;
500, d; 3, g; 5, T; 4, i. Gaps were closed in the biosynthetic
pathway genes with PCR and standard Sanger sequencing
performed by the DNA Analysis Facility on Science Hill at
Yale.
Genomic regions containing antibiotic biosynthetic gene
clusters were identified using AntiSMASH software (Weber et al.,
2015), IMG-AB database prediction (Hadjithomas et al., 2015)
and BLAST alignment tools (Altschul et al., 1990) to align
Streptomyces sp. 2AW sequences to related clusters. Streptomyces
sp. 2AW genome alignments were visualized using Circos
software (Krzywinski et al., 2009).
Phylogenetic Analysis
Protein sequence alignments were performed with MAFFT
version 7 (Katoh and Standley, 2013) and were manually adjusted
using as a guide the residues-wise confidence scores generated by
GUIDANCE2 (Sela et al., 2015). ProtTest 3 was used to select
the best-fit model of amino acid replacement (Darriba et al.,
2011). Phylogenetic relationships were inferred by maximum
likelihood using RAxML-HPC2 on XSEDE conducted on the
CIPRES project (Miller et al., 2010) cluster at the San Diego
Supercomputer Center. Phylogenetic trees were visualized using
FigTree software3.
RESULTS AND DISCUSSION
Identification of Antibiotics
We isolated a large collection of diverse bacteria from the
Bonanza Creek Long-Term Ecological Research Area in
Alaska and screened the collection for inhibitory activity
toward B. subtilis (Schloss et al., 2010). We identified
Streptomyces sp. strain 2AW, which was subsequently also
shown to inhibit E. coli and the oomycete plant pathogen,
P. ultimum. We purified three compounds by bioassay-
guided fractionation, one active against P. ultimum, one
against B. subtilis, and one against both E. coli and B. subtilis.
The structures of these three compounds, obtained by NMR
spectroscopy and/or mass spectrometry (MS), are consistent with
cycloheximide, neutramycin, and hygromycin A, respectively
(Figure 1).
Cycloheximide is an antifungal antibiotic first discovered
in Streptomyces griseus (Lyons and Pridham, 1966). It belongs
to the glutarimide class of antibiotics, all of which contain a
glutarimide ring with different polyketide substituents (Obrig
et al., 1971). Cycloheximide inhibits the eukaryotic ribosome
by binding to the E-site and interfering with the subsequent
binding of deacylated tRNA to this site (Schneider-Poetsch et al.,
2010).
Neutramycin is a neutral macrolide first identified from
S. rimosus and S. luteoverticillatus with inhibitory activity against
Gram-positive bacteria (Lefemine et al., 1963; Graziani et al.,
2003). The lack of a C6-methyl group differentiates neutramycin
3http://tree.bio.ed.ac.uk/software/figtree/
from the related antibiotic chalcomycin (Supplementary
Figure S5B) (Mitscher and Kunstmann, 1969; Ward et al., 2004).
Dihydrochalcomycin, an antibiotic isolated from Streptomyces
sp. KCTC 0041BP, is also structurally similar to neutramycin,
lacking a C6-methyl group and a 110,11 double bond (Pageni
et al., 2010).
The bioactivity, and accurate mass, and mass spectral
fragmentation patterns of the third antibiotic were consistent
with the glycosylated polyketide hygromycin A or epihygromycin
A (Wakisaka et al., 1980). NMR spectroscopy and MS also
revealed a compound whose structure we have been unable
to elucidate that might be related to hygromycin A; we also
found a previously characterized hygromycin A biosynthetic
intermediate methoxyhygromycin A (Supplementary Figure S5)
(Yoshida et al., 2014). Hygromycin A was first discovered
in isolates of S. hygroscopicus (before the discovery in the
same species of the structurally unrelated, but well-known
hygromycin B). Hygromycin A inhibits the bacterial ribosomal
peptidyltransferase in both Gram-negative and Gram-positive
bacteria (Guerrero and Modolell, 1980).
Sequence of Streptomyces sp. 2AW
Genome
The Streptomyces sp. 2AW genome was sequenced by 454 and
Illumina methodologies, resulting in 36 contigs organized into 12
scaffolds. The total length of the assembly was 9,449,583 bp
with an average G+C content of 70%. Supplementary
Table S4 summarizes the basic genomic characteristics. We
used Prodigal software (Hyatt et al., 2010) coupled with
the IMG/ER pipeline (Markowitz et al., 2009) to identify
8,241 putative protein-encoding genes, 70 tRNA genes, and
one rRNA operon. Supplementary Table S5 lists the genes
identified along with its corresponding annotation. As one
assessment of genome comprehensiveness, we evaluated
the completeness of a particular biochemical pathway (the
pyrimidine biosynthetic pathway), which did appear complete
in our database (Supplementary Figure S6). We detected 28
putative secondary metabolite gene clusters from a manual
comparison of the AntiSMASH software prediction and the
IMG-AB database prediction (Supplementary Figure S7)
(Hadjithomas et al., 2015; Weber et al., 2015). The genome
is available at JGI Genome Portal4 with the IMG Object ID
2606217189.
Identification of Biosynthetic Clusters
Hygromycin A
Analysis of the Streptomyces sp. 2AW genome revealed
a region that contains 78% nucleotide identity to the
published hygromycin A biosynthetic genes hyg2 to hyg27
from S. hygroscopicus strain NRRL 2388 (Palaniappan et al.,
2006). We predict that these genes encode the hygromycin A
biosynthetic enzymes, and based on the structural similarities
between hygromycin A, methoxyhygromycin A, and the
hygromycin A derivative, these genes may encode enzymes that
4http://genome.jgi.doe.gov
Frontiers in Microbiology | www.frontiersin.org 4 May 2016 | Volume 7 | Article 573
fmicb-07-00573 May 2, 2016 Time: 14:41 # 5
Stulberg et al. Genomic and Metabolite Analyses of 2AW
FIGURE 1 | Isolation of antibiotics from Streptomyces sp. 2AW. (A) Streptomyces sp. 2AW grown on solid culture with Gram-positive bacterium Bacillus
subtilis, the Gram-negative bacterium Escherichia coli, and the eukaryotic pathogen Pythium ultimum. (B) UPLC chromatogram of the Streptomyces sp. 2AW
extract, and (C) mass spectra of each active component confirming the exact masses and its corresponding structure. (D) Zones of inhibition of the HPLC fractions
showing the fractions’ activity against B. subtilis, E. coli, and P. ultimum.
catalyze modifications of the same compounds (Supplementary
Figure S8A).
Neutramycin
We found a gene cluster in 2AW that is likely to be
responsible for the biosynthesis of neutramycin based
on sequence identity and similar genetic organization of
the gene clusters underlying production of the related
antibiotics chalcomycin and dihydrochalcomycin in S.
bikiniensis and Streptomyces sp. KCTC 0041BP, respectively
(Supplementary Figure S8B) (Ward et al., 2004; Pageni et al.,
2010).
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FIGURE 2 | Proposed cycloheximide and other glutaramide biosynthetic pathways. (A) Proposed biosynthetic pathway of the five conserved modules of the
AT-less PKS of glutaramide antibiotics. A loading module (green): ACP, acyl carrier protein; AT, malonyl-CoA ACP transacylase; AMT, amidotransferase. An AT-less
modular type I polyketide synthase (PKS) region (gray): KS, ketosynthase; DH, dehydratase; ER, enoylreductase; MT, methyltransferase; ACP, acyl carrier protein; X,
uncharacterized cyclization domain; TE, thiosesterase. (B) Proposed catalytic domains and biosynthetic pathway including the Michael addition catalyzed by the X
uncharacterized domain to generate the characteristic glutaramide ring. (C) Proposed pathway for cycloheximide formation mediated by tailoring gene cluster.
(D) Proposed pathway for 9-methylstreptomidone formation. (E) Proposed pathway for iso-migrastatin formation. (F) Proposed pathway for lactimidomycin
formation. (C,E) Nucleotides of Saccharomyces cerevisiae 25S rRNA that directly interact with cycloheximide and lactimidomycin in the ribosome.
Cycloheximide
The cycloheximide biosynthetic gene cluster and proposed
biosynthetic pathway was recently identified from Streptomyces
sp. YIM56141 (Yin et al., 2014). This gene cluster shares
similar gene architecture with other glutarimide antibiotic gene
clusters (Lim et al., 2009; Wang et al., 2013) including: an acyl
carrier protein (ACP), a malonyl-CoA ACP transacylase (AT), an
asparagine synthase or amidotransferase (AMT), and an AT-less
modular type I polyketide synthase (PKS). The first three genes
are proposed to form the loading module, where AMT installs
the amide nitrogen at the free carboxylate, and coupled with the
first two modules of the PKS, they produce the characteristic
glutarimide ring (Figure 2A). In the second elongation module,
it was proposed that inclusion of an uncharacterized “X”
domain catalyzes the cyclization of the glutarimide ring in 9-
methylstreptimidone (Wang et al., 2013). The AT loads the ACP
with a malonate, but instead of typical decarboxylative addition
to the thioester of the ketosynthase-bound molecule, elongation
occurs through a Michael addition. This introduces a branch
point and leads to an intermediate that is tethered to both the
ACP and the KS. The glutarimide ring is formed through the
intramolecular acylation of the amide nitrogen by the thioester,
resulting in the release of the molecule from the KS (Figure 2B).
A cycloheximide-specific tailoring gene cluster downstream of
the PKS-encoding genes participates in the modification of the
nascent polyketide intermediate, first to actiphenol and finally to
cycloheximide (Figure 2C).
We identified a similar gene cluster in the Streptomyces
sp. 2AW genome. However, the tailoring gene cluster in
strain 2AW has an additional gene, and the entire tailoring
cluster is located in a different part of the genome, not
adjacent to the core PKS biosynthetic gene cluster as in
YIM56141 (Supplementary Figure S7). To further explore this
unexpected genetic arrangement, we identified a cycloheximide
biosynthetic gene cluster in the genome of S. griseus subsp. griseus
NBRC13350 with the core PKS biosynthetic genes adjacent to the
tailoring gene cluster that appeared more similar to YIM56141
(Figure 3).
Proposed Evolutionary Origin of the
Cycloheximide Biosynthetic Gene
Cluster
Based on the relatively low similarity between the cycloheximide
gene cluster in 2AW and the other strains, along with the
separation of the tailoring gene cluster in 2AW, we hypothesized
that the 2AW cycloheximide biosynthetic genes may reflect
a more ancestral version of the cycloheximide biosynthetic
pathway. In this model, the tailoring gene cluster initially
evolved in a different part of the chromosome, or in another
genome, from the glutarimide core PKS gene cluster, and an
in trans interaction of these two gene clusters gave rise to
cycloheximide as a novel secondary metabolite. Subsequent
evolution of the pathway resulted in the gene arrangement found
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FIGURE 3 | Comparison of the cycloheximide biosynthetic cluster from Streptomyces sp. 2AW to the putative clusters Streptomyces sp. YIM 56141
and S. griseus subsp. griseus NBRC 13350. Putative Streptomyces sp. 2AW cycloheximide genes homologous to Streptomyces sp. YIM 56141 genes
chxABCDE are separated from those homologous to chxFGHIJ.
in cycloheximide producers YIM56141 and NBRC13350, with the
core PKS and cycloheximide-specific genes clustered together.
We tested this hypothesis by comparing the proteins
that encode the tailoring gene clusters of the different
cycloheximide biosynthetic pathways, including a transcriptional
regulator, chxF; a enoylreductase, chxG; a ketoreductase, chxH;
a cytochrome P450 oxidoreductase, chxI; and a three-domain
carboxylic acid reductase, chxJ. In addition to the three strains
described above, cycloheximide-like gene clusters were identified
from seven additional Streptomyces and one Saccharopolyspora
genome and were included in our dataset (Supplementary
Table S6). In each case other than 2AW, the cycloheximide-
like gene clusters have the tailoring gene cluster adjacent to
the core PKS genes, as in the arrangement in YIM56141. One
new gene arrangement was found in the cycloheximide-like
gene clusters from Streptomyces sp. 769, Streptomyces noursei
ATCC11455, and Saccharopolyspora flava DSM44771, where
chxF is not between the PKS genes and chxG. In strains 769
and ATCC11455, chxF is downstream of the glutarimide core
gene cluster instead of a putative SARP transcriptional regulator
present in some of the glutarimide gene clusters. In addition,
the final domain in the PKS of strains 769, ATCC11544, and
DSM44711 is a condensation domain (IPR001242) instead of the
traditional thioesterase domain (IPR029802) present in the other
cycloheximide PKSs.
We conducted a maximum-likelihood analysis of the proteins
encoded by chxF, chxG, chxH, chxI, and chxJ. For all five of
these proteins, orthologs from strains 2AW, 769, ATCC11455,
and DSM44771 are in the basal portion of the tree relative to
the others (Figure 4), suggesting they may reflect more ancestral
lineages. However, there is not enough resolution to clarify the
relationship between these ancestral clusters within the well-
defined clade to which YIM56141 and NBRC13350 belong.
To further clarify the relationship between 2AW and the other
ancestral lineages, we attempted to reconstruct the phylogeny of
the core PKS gene cluster. The five modules that constitute the
cycloheximide PKS and cycloheximide-like PKS are conserved
in the biosynthesis of other glutarimide antibiotics such
as 9-methylstreptimidone, lactimidomycin and iso-migrastatin,
and in eight other glutaramide-like gene clusters found in
Actinomycetes and Burkholderia spp. genomes (Figure 5B;
Supplementary Table S6), even though only the first two PKS
modules are thought to be needed to generate the glutaramide
ring (Figure 2A). This observation suggests that the glutarimide
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FIGURE 4 | Phylogenetic analysis of the proteins present in the cycloheximide tailoring gene cluster. (A) Schematic representation of the cycloheximide
tailoring gene cluster organization. (B) Maximum likelihood phylogenetic tree estimated of the protein sequence of each tailoring gene cluster.
biosynthesis family may have evolved from a basic five-module
PKS.
The results above also suggested that the PKSs of the
other glutaramide gene cluster might help to resolve the
relationship between 2AW and the other cycloheximide-like
gene clusters. The ketosynthase domain (KS) is commonly used
to determine relationships between PKSs, because it is one of
the essential domains present in the modules. We therefore
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FIGURE 5 | Phylogenetic analysis and comparison of diverse glutaramide gene clusters. (A) Maximum likelihood phylogenetic tree estimated of the protein
sequence of the first ketosynthase domain in the PKS of diverse glutaramide gene clusters. (B) Schematic representation of glutarimide gene clusters. In green,
loading module: ACP, acyl carrier protein; AT, malonyl-CoA ACP transacylase; AMT, amidotransferase. In gray: PKS, AT-less modular type I polyketide synthase;
Gray-scale represented different genes to codify the multi-protein complex. Rounded rectangle, PKS domains: KS, ketosynthase; DH, dehydratase; ER,
enoylreductase; MT, methyltransferase; ACP, acyl carrier protein; X, uncharacterized cyclization domain; TE, thiosesterase; Cn, condensation. Circles, NRPS
domains: C, condensation; A, adenylation; PCP, thiolation and peptide carrier protein; NMT, methylation. In blue, cycloheximide gene cluster; dark blue
transcriptional regulator, light blue tailoring. ∗∗∗Partial PKS.
conducted Maximum-likelihood analysis using the amino acid
sequence of the first KS domain (KSI) as a representative of
the entire PKS of all glutarimide gene clusters identified in
public databases (Figure 5A), including three partial gene clusters
(Supplementary Table S6). Lactimidomycin (LmtE) and iso-
migrastatin (MgsE), which have similar gene clusters sharing
additional modules in the PKSs, group together with the other
four clusters that also share additional modules. These form a
unique clade that diverged early from the other glutarimide-
like clusters. The partial glutarimide-like gene cluster from an
uncultured bacterial clone appears to be the most divergent
among the gene clusters. For cycloheximide clusters, 2AW is next
to and in a basal position to the other seven cycloheximide-like
clusters, which grouped together in the previous phylogenetic
trees. Meanwhile, 279, ATCC11455, and DSM44771 are located
closer to other glutarimide clusters than to cycloheximide-
specific clusters. Although there is not enough resolution to
clarify the relationships between 279, ATCC11455, DSM44771,
and the other glutaramide gene clusters, the phylogenetic analysis
shows that the 2AW gene cluster is more closely related to the
other cycloheximide gene clusters and may resemble an ancestral
state in the evolution of the cycloheximide pathway. Phylogeny
of an additional coding sequence of the AT gene showed a similar
topology to that in the KSI tree (Supplementary Figure S9).
We postulate an evolutionary scenario in which the structural
gene cluster and the tailoring gene cluster for cycloheximide
production evolved independently of each other. The tailoring
cluster accumulated genes that encode proteins with very diverse
enzymatic activity. The 2AW tailoring gene cluster has an
additional gene, designated here as orfX, which contains a
condensation domain associated with non-ribosomal peptide
synthetases. We hypothesize that this tailoring gene cluster
evolved as a toolkit with a broad spectrum of activity, increasing
the likelihood of interaction with other secondary metabolite
gene clusters. Following its incorporation into a genome where
it could interact with an ancestral glutarimide core gene cluster,
the tailoring gene cluster lost genes not needed for activity,
as we observe with orfX. The hypothesis of an independently
evolved tailoring cluster may explain the different location of 279,
ATCC11455, and DSM44771 in the KSI and AT tree relative to
the other cycloheximide-like clusters. We hypothesize at least two
independent events in which an ancestral tailoring gene cluster
combined with an ancestral glutarimide core gene cluster. One
such event produced a complete fusion of the two gene clusters
where both gene clusters share the same transcriptional regulator,
chxF, as in 279 and ATCC11455. Another such genetic event
produced the fusion of the two gene clusters, maintaining within
each cluster a transcriptional regulator, as in the YIM56141
gene cluster. Fusion of the two gene clusters then enabled
the transfer and dissemination of a contiguous cycloheximide
pathway cluster.
Chemical Diversification in the
Glutarimide Family
Diverse glutaramide antibiotics, such as isomigrastatin,
lactimidomycin, streptimidone, and cyclohemiximide are
known to inhibit eukaryotic translation. However, the potency
of these antibiotics varies, and activity is correlated with the
size of the moiety associated with the glutaramide ring (Obrig
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et al., 1971; Schneider-Poetsch et al., 2010). Crystal structures
of 80S ribosomes from Saccharomyces cerevisiae in complex
with lactimidomycin and cyclohemiximide indicate the location
of the glutaramide ring in a pocket formed by universally
conserved nucleotides of the 25S rRNA in the E-site. In addition
to the hydrogen bonds formed between the 25S rRNA and the
glutaramide ring, there are additional bonds with the succeeding
hydroxyl and ketone group made in the first five modules of
the PKSs (Garreau de Loubresse et al., 2014; Figures 2C–F).
This structural observation could explain the conservation of
the same five modules identified in all PKSs of the glutaramide
family because the additional bonds create a strong interaction
between the antibiotic and the ribosome. The interaction may
have led to selection of the additional moieties, leading to
highly diverse active compounds, since the glutarimide ring
is necessary, but not sufficient, for activity (Schneider-Poetsch
et al., 2010).
We propose an ancestral glutarimide core gene cluster formed
from an ACP, a malonyl-CoA transacylase, an amidotransferase,
and an AT-less PKS containing the five conserved modules.
All glutaramide antibiotics evolved from this ancestral core
gene cluster through a variety of strategies that resulted in the
modification of the accessory moiety attached to the glutarimide
ring. Phylogenetic analyses of the KSI and AT suggest an early
evolution of the core gene cluster through the addition of five
modules in the PKS, followed by loss-of-function mutations and
duplication of the internal domain, thereby leading to pathways
for the production of lactimidomycin and iso-migrastatin
(Figures 2E,F). Interestingly, we identified a different strategy
for increasing modules in the core gene cluster in the genome
of Kitasatospora mediocidica, in which we identified a non-
ribosomal peptide synthetase after the PKS, suggesting a hybrid
PKS–NRPS. Another strategy to increase the chemical diversity
of a basic glutarimide precursor may have been to maintain the
same number of modules but to use a module iteratively, as
in 9-methylstreptimidone (Figure 2D), or through the use of
a tailoring gene cluster to modify a glutarimide precursor in
trans, as in the case of cycloheximide (Figure 2C). The use of
tailoring gene clusters to modify a scaffold is a common strategy
to increase chemical diversity, and the glycopeptide family of
antibiotics is just one example of how diverse modifications of
the core heptapeptide scaffold produced by NRPSs can increase
chemical diversity (Yim et al., 2014). Additional genes or gene
clusters next to the NRPSs generate different modifications,
such as glycosylation, acylation, chlorination, sulfonation, and
methylation. However, the use of diverse tailoring gene clusters
can create unique molecules too, such as in the example
of simocyclinone, which is the assemblage of four different
moieties, angucycline, dTDP-D-olivose, aminocoumarin and a
linear polyene, produced by the fusion of four gene clusters
(Trefzer et al., 2002).
CONCLUSION
We identified three different antibiotics from Streptomyces sp.
2AW, an Alaskan soil isolate. Through comparative analysis
of the Streptomyces sp. 2AW genome with other antibiotic-
producing strains, we identified the antibiotic biosynthetic
gene clusters and additional putative secondary metabolite
gene clusters. These putative gene clusters likely produce
metabolites we have not yet detected but which could be of
scientific or clinical use. Unexpectedly, the cycloheximide
gene cluster from our strain differed significantly from those
previously identified. Analysis of this secondary metabolite gene
cluster by sequence comparison defined several cycloheximide-
like gene clusters as ‘other glutaramide-like gene clusters’
in public databases. Comparisons of the different gene
clusters coupled with phylogenetic analysis of key proteins
enabled us to propose a model in which cycloheximide
biosynthetic genes evolved from an ancestral glutaramide
core gene cluster through the addition of a tailoring gene
cluster, with 2AW representing an intermediate step in
pathway organization. Our results highlight the use and
power of modern sequencing technologies and bioinformatics
to advance our understanding of Streptomyces metabolite
biosynthesis. Altogether, this work demonstrates how research in
understudied natural environments, natural products chemistry,
and bioinformatics can be combined to identify antibiotics
and better understand the evolution of secondary metabolite
biosynthetic pathways.
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FIGURE S6 | Streptomyces sp. 2AW pyrimidine biosynthesis pathway.
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(B) Streptomyces sp. 2AW genes to codify the corresponding step in the
pyrimidine biosynthesis.
FIGURE S7 | Schematic representation of the Streptomyces sp. 2AW
genome. All genes are color-coded, reverse and forward strand. The inside circle
represents the location of the putative secondary metabolite gene clusters,
color-coded by type. The scale is numbered in megabases.
FIGURE S8 | Comparisons of neutramycin and hygromycin A biosynthetic
clusters to known clusters of related metabolites. (A) Putative hygromycin A
gene cluster compared to S. hygroscopicus NRRL 238826, and (B) putative
neutramycin gene cluster compared to chalcomycin and dihydrochalcomycin
clusters in S. bikiniensis and Streptomyces sp. KCTC 0041 BP, respectively.
FIGURE S9 | Phylogenetic analysis of the malonyl-CoA ACP transacylase
protein present in glutaramide gene cluster. Maximum likelihood phylogenetic
tree estimated of the AT protein sequence associated with glutaramide AT-less
modular type I PKS as AT associates with others AT-less modular type I PKSs.
TABLE S1 | Nuclear magnetic resonance (NMR) spectral data for
cycloheximide.
TABLE S2 | Nuclear magnetic resonance spectral data for neutramycin.
TABLE S3 | Nuclear magnetic resonance spectral data for hygromycin A.
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